Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is taken once a week, and you can take it on any day of the week, at any time of day — the timing is yours to choose. What matters is consistency: picking the same day each week, so doses stay roughly 7 days apart. It is a prescription-only medicine, and a prescriber determines whether it is suitable for you before treatment begins. Here is what the clinical guidance actually says about timing, and why some of the common worries around it are simpler to resolve than you might expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is one of the questions our prescribers hear regularly, and the answer is reassuring. Unlike some daily medicines that depend on a precise window, Mounjaro works on a weekly cycle. The NHS patient guidance on tirzepatide confirms it can be taken at any time of day, with or without food. There is no evidence that taking it at 7am performs differently from 7pm.
What does matter is the gap between doses. Keeping to the same weekday each week means you are automatically maintaining that 7-day spacing without having to count. A helpful habit: when your pen arrives, put a recurring reminder in your phone calendar for that day. It takes about 30 seconds and removes the mental load entirely.
If your chosen day needs to shift occasionally (say, you are travelling and your Monday falls awkwardly) the SmPC allows a short-term change, provided at least 3 days have passed since your last injection. Anything more complicated than that is worth a quick message to your prescriber rather than a guess. For a deeper look at the once-weekly schedule and what it means in practice, the guide on how often Mounjaro is taken covers the full picture.
Knowing when you should take Mounjaro is only half the picture. There are circumstances where skipping a dose and seeking advice is the right call. The NHS tirzepatide guidance is clear that severe, persistent stomach pain (particularly pain that spreads towards the back, with or without vomiting) should prompt urgent medical attention rather than a self-managed dose. This is the pattern associated with acute pancreatitis, which the MHRA flagged in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines.
Other situations where you should pause and contact a clinician: signs of an allergic reaction (swelling, rash, difficulty breathing), severe or persistent vomiting that means you cannot keep fluids down, or if you are pregnant, think you may be pregnant, or are planning a pregnancy. Mounjaro is not recommended during pregnancy or breastfeeding, and the prescriber who manages your treatment is the right first call in any of these scenarios.
If you are unsure whether a particular health condition or other medicine you take means you should not be on Mounjaro at all, that question belongs in a clinical consultation, not a search result.
The practical answer to "when should I take Mounjaro" is: whenever fits your week, repeated reliably. Some people prefer Sunday evenings because the working week hasn't started and they're at home. Others choose a weekday morning to link it to another routine. Neither is clinically superior.
One detail worth knowing: the injection itself takes a few seconds, but you will want to let the pen reach room temperature for around 30 minutes before use, taking it straight from the fridge can make the injection less comfortable. Checking the pen is in good condition and noting the expiry date before you draw it from the fridge is a sensible one-minute habit. If you notice any unusual swelling in your legs around the time you take your dose, our page on whether Mounjaro causes leg swelling explains what the evidence shows and when it is worth raising with your prescriber.
Injection site rotation matters too, abdomen, thigh, and upper arm are all suitable, and switching between them across weeks reduces localised skin irritation. Full storage and administration detail lives in your Patient Information Leaflet; the NHS tirzepatide page is also a reliable quick reference. For the broader question of whether Mounjaro is right for your situation at all, this page on deciding whether Mounjaro suits you walks through the eligibility and clinical considerations.
Cost questions come up in this context too, some people switch injection day or miss doses because they are rationing pens. If cost is a concern, our guide to Mounjaro pricing in the UK explains what the market looks like and what a legitimate private prescription actually includes. Cutting corners on supply is a different kind of risk to the timing question, and worth understanding separately.
If you are approaching a decision about starting treatment, or you are already on Mounjaro and wondering whether to continue, when to stop Mounjaro covers the clinical signals that a prescriber would typically consider. And if you have not yet started, check your eligibility with our prescribers, the consultation is free, and a real clinician reviews your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.